{"id":"nct:NCT07566104","kind":"trial","title":"Group PACBT for Depression","authors":["University of California, Los Angeles"],"author_count":1,"year":2026,"published":"2026-05-04","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT07566104","source_url":"https://clinicaltrials.gov/study/NCT07566104","archive_url":"https://space-kitty.com/papers/nct:NCT07566104","updated":"2026-05-04","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"This study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms and psychosocial functioning.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Depression - Major Depressive Disorder","Psilocybin","Cognitive Behavioral Therapy"],"details":{"acronym":null,"status":"NOT_YET_RECRUITING","phase":"PHASE2","study_type":"INTERVENTIONAL","enrollment":30,"sponsor":"University of California, Los Angeles","conditions":["Depression - Major Depressive Disorder","Psilocybin","Cognitive Behavioral Therapy"],"interventions":["DRUG: Psilocybin (drug)","BEHAVIORAL: Group Cognitive Behavioral Therapy"],"start_date":"2027-01-01","start_date_type":"ESTIMATED","primary_completion_date":"2028-12-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"psychiatric-therapeutics","name":"Novel Psychiatric Therapeutics","domain_slug":"neuroscience"}],"cited_in_dossiers":[]}